Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
PT-141, also known as Bremelanotide, is a synthetic peptide utilized to treat sexual dysfunction in both men and women
This work was supported by the Wilmot Cancer Institute Predoctoral Fellowship (G.A.), Wilmot Cancer Institute Pilot Funding (I.S.H.), the American Association for Cancer Research and Breast Cancer Research Foundation (20-20-26-HARR) (I.S.H.), Breast Cancer Coalition of Rochester (I.S.H.), a Sir Henry Wellcome Postdoctoral Fellowship (M.E.K.), and a FNR-CORE grant C21/BM/15796788 (D.B.), and NIH grants R01CA269813 (I.S.H.), R37CA230042 (G.M.D), R24AA022057 (V.V.), R01AA028859 (Y.C.), AI150698 (J.M.), K01CA240533-01A1 (C.L.C.), and R01AR078000 (R.T.D.)
Zhou K, Lu D, You J, Liu T, Sun J, Lu Y, et al
Although this study yielded several meaningful findings, there are still some limitations
US$ 29.19
US$ 22.32
US$ 29.21
US$ 28.74
US$ 29.02
